In addition, in vivo studies have demonstrated that TASIN-1 can inhibit the growth of APC-truncated CRC cells without deleterious effects on the normal colonic epithelium, although it is not currently under clinical application. The gene discussed is APC; the disease is colorectal carcinoma.